Innoviva Inc (INVA)
14.99
-0.17
(-1.12%)
USD |
NASDAQ |
Apr 25, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
Innoviva Price to Book Value: 1.404 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.404 |
| April 24, 2024 | 1.420 |
| April 23, 2024 | 1.421 |
| April 22, 2024 | 1.399 |
| April 19, 2024 | 1.400 |
| April 18, 2024 | 1.376 |
| April 17, 2024 | 1.356 |
| April 16, 2024 | 1.356 |
| April 15, 2024 | 1.349 |
| April 12, 2024 | 1.370 |
| April 11, 2024 | 1.378 |
| April 10, 2024 | 1.368 |
| April 09, 2024 | 1.379 |
| April 08, 2024 | 1.380 |
| April 05, 2024 | 1.373 |
| April 04, 2024 | 1.373 |
| April 03, 2024 | 1.387 |
| April 02, 2024 | 1.386 |
| April 01, 2024 | 1.425 |
| March 28, 2024 | 1.428 |
| March 27, 2024 | 1.432 |
| March 26, 2024 | 1.403 |
| March 25, 2024 | 1.414 |
| March 22, 2024 | 1.414 |
| March 21, 2024 | 1.404 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.386 |
| March 19, 2024 | 1.370 |
| March 18, 2024 | 1.364 |
| March 15, 2024 | 1.392 |
| March 14, 2024 | 1.379 |
| March 13, 2024 | 1.382 |
| March 12, 2024 | 1.388 |
| March 11, 2024 | 1.386 |
| March 08, 2024 | 1.390 |
| March 07, 2024 | 1.413 |
| March 06, 2024 | 1.422 |
| March 05, 2024 | 1.394 |
| March 04, 2024 | 1.430 |
| March 01, 2024 | 1.428 |
| February 29, 2024 | 1.431 |
| February 28, 2024 | 1.438 |
| February 27, 2024 | 1.440 |
| February 26, 2024 | 1.454 |
| February 23, 2024 | 1.450 |
| February 22, 2024 | 1.450 |
| February 21, 2024 | 1.468 |
| February 20, 2024 | 1.480 |
| February 16, 2024 | 1.486 |
| February 15, 2024 | 1.499 |
| February 14, 2024 | 1.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.258
Minimum
Oct 27 2023
8.042
Maximum
May 06 2019
2.810
Average
2.567
Median
Aug 01 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.699 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6516 |
| Theriva Biologics Inc | 0.1902 |
| Oragenics Inc | 3.015 |
Price to Book Value Related Metrics
| PE Ratio | 6.876 |
| PS Ratio | 3.940 |
| PEG Ratio | 0.9306 |
| Price to Free Cash Flow | 8.697 |
| Price | 14.99 |
| Earnings Yield | 14.54% |
| Market Cap | 947.78M |
| PEGY Ratio | 0.9306 |
| Operating PE Ratio | 10.74 |
| Normalized PE Ratio | 7.200 |